Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “B-Cell Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04952974
What this trial is testing

B-cell Chronic Lymphoid Malignancies Markers

Who this might be right for
Chronic Lymphocytic LeukemiaMarginal Zone LymphomaLymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia+3 more
University Hospital, Strasbourg, France 420
Testing effectiveness (Phase 2)Ended earlyNCT02983097
What this trial is testing

Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)Follicular Lymphoma Grade III (FL III°)Mantle Cell Lymphoma (MCL), Blastoid Variant+2 more
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 34
Testing effectiveness (Phase 2)Study completedNCT00622388
What this trial is testing

Ofatumumab in Patients With Relapsed/Progressive Diffused Large B-Cell Lymphoma (DLBCL) Ineligible for or Relapse/Progression After Transplant

Who this might be right for
Lymphoma, Large-Cell, Diffuse
GlaxoSmithKline 81
Testing effectiveness (Phase 2)Looking for participantsNCT06542250
What this trial is testing

Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

Who this might be right for
B-cell Malignancies
AstraZeneca 174
Testing effectiveness (Phase 2)WithdrawnNCT03719560
What this trial is testing

Early Systemic Central Nervous System Prophylaxis in Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
Brown University
Testing effectiveness (Phase 2)Study completedNCT00324779
What this trial is testing

Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic Leukemia

Who this might be right for
LeukemiaLymphoma
University Hospital Erlangen 79
Not applicableLooking for participantsNCT05621291
What this trial is testing

Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...

Who this might be right for
B-AllAcute Lymphoblastic Leukemia
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT00373646
What this trial is testing

Thalidomide in Mucosa Associated Lymphoid Tissue (MALT) Lymphoma Patients

Who this might be right for
MALT Lymphoma
Medical University of Vienna 8
Not applicableUnknownNCT03265158
What this trial is testing

Blood Immunophenotyping in Staging of Indolent B-cell Lymphomas V1.0

Who this might be right for
Follicular Lymphoma (FL)Mantle Cell Lymphoma (MCL)Marginal Zone Lymphoma (MZL)
Royal Marsden NHS Foundation Trust 108
Testing effectiveness (Phase 2)Study completedNCT00156013
What this trial is testing

Clofarabine for Relapsed or Refractory T-Cell or B-Cell Non-Hodgkin Lymphoma (NHL)

Who this might be right for
Lymphoma, B-CellLymphoma, Non-Hodgkin
Oncology Specialists, S.C. 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT03075696
What this trial is testing

A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Hoffmann-La Roche 940
Not applicableActive Not RecruitingNCT01829958
What this trial is testing

Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy

Who this might be right for
Non Hodgkin Lymphoma (NHL)Diffuse Large B-cell Lymphoma (DLBCL)
Memorial Sloan Kettering Cancer Center 201
Large-scale testing (Phase 3)Study completedNCT00004218
What this trial is testing

Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
Leukemia Research Fund
Testing effectiveness (Phase 2)Study completedNCT02340780
What this trial is testing

Buparlisib in Patients With Relapsed and Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Canadian Cancer Trials Group 14
Testing effectiveness (Phase 2)Looking for participantsNCT07609862
What this trial is testing

Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies

Who this might be right for
Mantle Cell Lymphoma (MCL)Diffuse Large B-Cell Lymphoma (DLBCL)Follicular Lymphoma ( FL)+2 more
Guangzhou Lupeng Pharmaceutical Company LTD. 92
Testing effectiveness (Phase 2)Study completedNCT01562990
What this trial is testing

Phase Ib/II Study of the Efficacy and Safety of the R-CMC544/R-GEMOX Combination in Diffuse Lage B-cell Lymphoma at First or Second Relapse

Who this might be right for
Diffuse Large B-Cell Lymphoma
The Lymphoma Academic Research Organisation 11
Early research (Phase 1)Ended earlyNCT01005979
What this trial is testing

A Phase I Trial Using Cyclophosphamide, Rituximab and Revlimid (CR2) for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL) and Small Lymphocytic Lymphoma (SLL)

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-CellChronic Lymphocytic LeukemiaLymphoma, Small Lymphocytic
Emory University 6
Early research (Phase 1)Study completedNCT02071888
What this trial is testing

Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)Multiple MyelomaWaldenstrom's Macroglobulinemia (WM)+2 more
Calithera Biosciences, Inc 25
Early research (Phase 1)Looking for participantsNCT05107674
What this trial is testing

NX-1607 in Adults With Advanced Malignancies

Who this might be right for
Ovarian Cancer, EpithelialGastric CancerGastroEsophageal Junction (GEJ) Cancer+11 more
Nurix Therapeutics, Inc. 345
Testing effectiveness (Phase 2)Active Not RecruitingNCT07153796
What this trial is testing

A Phase 1b/2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Combination With Low Intensity Chemotherapy in Older Patients With Newly Diagnosed B-Cell Acute Lymphoblastic Leukemia

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center 3
Next Page